CAS 960201-81-4

rel-6,7-Dimethyl (1R,5R,6R,7S)-4-oxo-8-(phenylmethyl)-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylate

Description:

Rel-6,7-Dimethyl (1R,5R,6R,7S)-4-oxo-8-(phenylmethyl)-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylate, with CAS number 960201-81-4, is a complex organic compound characterized by its bicyclic structure, which includes a nitrogen atom in the ring system. This compound features multiple functional groups, including a ketone and two carboxylate moieties, contributing to its potential reactivity and solubility properties. The presence of the phenylmethyl group enhances its lipophilicity, which may influence its biological activity and interaction with various biological targets. The stereochemistry indicated by the (1R,5R,6R,7S) configuration suggests specific spatial arrangements of atoms that can significantly affect the compound's pharmacological properties. Such compounds are often studied for their potential applications in medicinal chemistry, particularly in the development of pharmaceuticals. Overall, the unique structural features and functional groups of this compound make it a subject of interest in chemical research and drug development.

Formula: C₁₈H₁₉NO₅

InChI: InChI=1/C18H19NO5/c1-23-17(21)14-12-8-9-13(20)16(15(14)18(22)24-2)19(12)10-11-6-4-3-5-7-11/h3-9,12,14-16H,10H2,1-2H3/t12-,14-,15-,16+/s2

InChI key: InChIKey=PYZQFEIRZQYUJQ-OYSMYPGONA-N

SMILES: C(N1[C@@]2([C@H](C(OC)=O)[C@H](C(OC)=O)[C@]1(C=CC2=O)[H])[H])C3=CC=CC=C3

Synonyms:

• rel-6,7-Dimethyl (1R,5R,6R,7S)-4-oxo-8-(phenylmethyl)-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylate
• 8-Azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid, 4-oxo-8-(phenylmethyl)-, 6,7-dimethyl ester, (1R,5R,6R,7S)-rel-
• SD 1008

SD 1008

CAS: 960201-81-4

SD 1008 is a histone lysine modulator that has been shown to improve memory in animal models of Alzheimer's disease. It works by binding to the active site of the enzyme acetylcholinesterase, which breaks down the brain chemical acetylcholine. SD 1008 also reduces virus-induced cell degranulation and synapses in mouse brains. It is a conjugate of pyridine compounds with polymer chains that signal transducers and are targeted for cancer therapy. The structure of SD 1008 is similar to other drug molecules that have been developed for cancer treatment, including drugs targeting integrin receptors. This similarity may be useful when treating cancers that express this receptor as it may help reduce side effects caused by these drugs.

Formula: C₁₈H₁₉NO₅

Purity: Min. 95%

Molecular weight: 329.35 g/mol

Ref: 3D-KNB20181

SD 1008

CAS: 960201-81-4

SD 1008 is a JAK2/STAT3 signaling pathway inhibitor. SD 1008 inhibits activation of STAT3, JAK2, and Src.

Formula: C₁₈H₁₉NO₅

Purity: 98%

Color and Shape: Solid

Molecular weight: 329.35

Ref: TM-T23340